Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes, CLC Bio Ink Licensing Pact

NEW YORK (GenomeWeb News) – ImaGenes will provide its next-generation sequencing customers with a license to CLC Bio’s Genomics Workbench for sequence analysis applications under a new bundling agreement, CLC Bio said today.

ImaGenes Director of Bioinformatics and Services Steffen Henning said in a statement that the firm sought "a software platform which we could use to present our research results to our customers in an easy, coherent, and user-friendly way," and which would function with various next-generation sequencing platforms.

The bundling agreement enables ImaGenes to provide all of its customers who receive next-generation sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.